Abstract Objective To examine the clinical characteristics,treatment,and prognosis of patients with synchronous head and neck and esophageal cancer (SHNEC). Methods The clinical data of 30 SHNEC patients treated in the Department of Radiotherapy of the First Affiliated Hospital of China Medical University from 2010 to 2014 were retrospectively reviewed. The patients were followed up and survival was calculated using the Kaplan-Meier method. Differences between survival curves were analyzed by the log-rank test,and prognostic analysis was performed using the Cox regression model. At the same and different time,the comprehensive diagnosis were 24 cases and 6 cases.21 patients were treated with radiochemotherapy, 9 patients were treated by surgery and radiotherapy±chemotherapy. Results SHNEC was frequently found in elderly men with heavy drinking and smoking habits. Hypopharyngeal cancer with middle esophageal cancer was most common among the patients;of the 30 patients,23(77%) had hypopharyngeal cancer,and 12(40%) had hypopharyngeal cancer with middle esophageal cancer. The median survival time of the patients was 20 months,and the 1-and 2-year overall survival (OS) rates were 83% and 37%,respectively. Univariate analysis showed that the stage of esophageal cancer,heavy smoking and drinking habits,and a family history of cancer were significantly associated with patient prognosis (P=0.009,0.044,0.012). In addition,the Cox analysis also demonstrated that the stage of esophageal cancer (HR=3.53,P=0.008),heavy smoking and drinking habits (HR=2.33,P=0.049),and a family history of cancer (HR=2.78,P=0.026) were independent prognostic factors. Conclusions Hypopharyngeal and middle esophageal cancer is the most common type of SHNEC,and the stage of esophageal cancer and heavy smoking and drinking habits are significantly associated with the prognosis of SHNEC patients. In addition,patients with stage Ⅰ and Ⅱ esophageal cancer can also achieve acceptable survival after receiving radiotherapy-based comprehensive treatment.
Corresponding Authors:
Li Guang,Email:13804058616@163.com
Cite this article:
Li Sihan,Chen Zhiqin,Li Guang. A clinical analysis of 30 patients with synchronous head and neck and esophageal cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(7): 728-731.
Li Sihan,Chen Zhiqin,Li Guang. A clinical analysis of 30 patients with synchronous head and neck and esophageal cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(7): 728-731.
[1] Marur S,Forastiere AA.Head and neck squamous cell carcinoma:update on epidemiology,diagnosis,and treatment[J].Mayo Clin Proc,2016,91(3):386-396.DOI:10.1016/j.mayocp.2015.12.017. [2] Slaughter DP,Southwick HW,Smejkal W.“Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin[J].Cancer,1953,6(5):963-968.DOI:10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q. [3] Lin KT,Lin CS,Lee SY,et al. Risk of esophageal cancer following percutaneous endoscopic gastrostomy in head and neck cancer patients:a nationwide population-based cohort study in Taiwan[J].Medicine,2016,95(9):e2958.DOI:10.1097/md.0000000000002958. [4] Park JW,Lee SW.Clinical outcomes of synchronous head and neck and esophageal cancer[J].Radiat Oncol J,2015,33(3):172-178.DOI:10.3857/roj.2015.33.3.172. [5] 赵俊华,白露,赵连爽,等.放化疗治愈下咽癌合并中段食管癌 1例及文献复习[J].中国医科大学学报,2012,41(7):661,666.DOI:10.3969/j.issn.0258-4646.2012.07.024. Zhao JH,Bai L,Zhao LS,et al. Hypopharyngeal and middle esophageal carcinoma cured by radiochemotherapy:one case report and literature review[J].J China Med Univ,2012,41(7):661,666.DOI:10.3969/j.issn.0258-4646.2012.07.024. [6] Chung CS,Lo WC,Wen MH,et al. Long term outcome of routine image-enhanced endoscopy in newly diagnosed head and neck cancer:a prospective study of 145 patients[J].Sci Rep,2016,6:29573.DOI:10.1038/srep29573. [7] Warren S,Gates O.Multiple primary malignant tumors. A survey of the literature and a statistical study[J].Am J Cancer,1932,16:1358-1414. [8] 中国非手术治疗食管癌临床分期专家小组.非手术治疗食管癌的临床分期标准(草案)[J].中华放射肿瘤学杂志,2010,19(3):179-180.DOI:10.3760/cma.j.issn.1004-4221.2010.03.001. Chinese non surgical treatment of clinical staging of esophageal cancer expert group. Clinical non operative treatment of esophageal cancer staging criteria (Draft)[J].Chin J Radiat Oncol,2010,19(3):179-180.DOI:10.3760/cma.j.issn.1004-4221.2010.03.001. [9] Welz S,Schmid A,Hehr T,et al. Treatment-outcome for synchronous head-and-neck and oesophageal squamous cell carcinoma[J].Radiother Oncol,2005,77(3):267-270.DOI:10.1016/j.radonc.2005.07.004. [10] Nandy N,Dasanu CA.Incidence of second primary malignancies in patients with esophageal cancer:a comprehensive review[J].Curr Med Res Opin,2013,29(9):1055-1065.DOI:10.1185/03007995.2013.816276. [11] Miyazaki T,Sohda M,Higuchi T,et al. Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer[J].Anticancer Res,2014,34(1):283-287. [12] Shinoto M,Shioyama Y,Sasaki T,et al. Clinical results of definitive chemoradiotherapy for patients with synchronous head and neck squamous cell carcinoma and esophageal cancer[J].Am J Clin Oncol,2011,34(4):362-366.DOI:10.1097/COC.0b013e3181e84b4b. [13] Guillot T,Spielmann M,Kac J,et al. Neoadjuvant chemotherapy in multiple synchronous head and neck and esophagus squamous cell carcinomas[J].Laryngoscope,1992,102(3):311-319.DOI:10.1288/00005537-199203000-00013. [14] Matsumoto A,Watanabe M,Shigaki H,et al. Efficacy of staged treatment strategy for patients with synchronous double cancers of the esophagus and head and neck:a retrospective study[J].World J Surg,2016,40(2):388-394.DOI:10.1007/s00268-015-3276-1. [15] Lim H,Kim DH,Jung HY,et al. Clinical significance of early detection of esophageal cancer in patients with head and neck cancer[J].Gut Liver,2015,9(2):159-166.DOI:10.5009/gnl13401. [16] Kuang JJ,Jiang ZM,Chen YX,et al. Smoking exposure and survival of patients with esophagus cancer:a systematic review and meta-analysis[J].Gastroenterol Res Pract,2016,2016:7682387.DOI:10.1155/2016/7682387. [17] Huang QY,Luo KJ,Yang H,et al. Impact of alcohol consumption on survival in patients with esophageal carcinoma:a large cohort with long-term follow-up[J].Cancer Sci,2014,105(12):1638-1646.DOI:10.1111/cas.12552. [18] Peng Q,Chen H,Huo JR.Alcohol consumption and corresponding factors:a novel perspective on the risk factors of esophageal cancer[J].Oncol Lett,2016,11(5):3231-3239.DOI:10.3892/ol.2016.4401. [19] Prabhu A,Obi KO,Rubenstein JH.The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma:a meta-analysis[J].Am J Gastroenterol,2014,109(6):822-827.DOI:10.1038/ajg.2014.71. [20] Yaegashi Y,Onoda T,Morioka S,et al. Joint effects of smoking and alcohol drinking on esophageal cancer mortality in Japanese men:findings from the Japan collaborative cohort study[J].Asian Pac J Cancer Prev,2014,15(2):1023-1029. [21] Sun P,Chen C,Zhang F,et al. Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinoma[J].Onco Targets Ther,2016,9:4257-4264.DOI:10.2147/ott.s104182. [22] 温登瑰,王士杰,张立玮,等.1702例食管鳞状上皮癌家族史与发病及预后关系的研究[J].中国肿瘤临床,2010,37(8):452-456.DOI:10.3969/j.issn.1000-8179.2010.08.009. Wen DG,Wang SJ,Zhang LW,et al. Analygsis of the relationship between familial history and esophageal squamous cell carcinoma in 1702 cases[J].Chin J Clin Oncol,2010,37(8):452-456.DOI:10.3969/j.issn.1000-8179.2010.08.009. [23] Jia N,Wen XD,Zhang N,et al. Younger age of onset and multiple primary lesions associated with esophageal squamous cell carcinoma cases with a positive family history of the cancer suggests genetic predisposition[J].Chin Med J,2014,127(15):2779-2783.DOI:10.3760/cma.j.issn.0366-6999.20140119.
2017, Vol. 26 
